|
|
Article: Celiac Disease - Licensing Opportunities Exist In Untapped Market as Report Estimates That under Optimal Conditions Drug Sales Could Reach $8 Billion By 2019.
- Article from:
- M2 Presswire
- Article date:
- May 6, 2009
CopyrightCOPYRIGHT 2009 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-6 May 2009-Research and Markets: Celiac Disease - Licensing Opportunities Exist In Untapped Market as Report Estimates That under Optimal Conditions Drug Sales Could Reach $8 Billion By 2019(C)1994-2009 M2 COMMUNICATIONS LTD
RDATE:07052009
Dublin - Research and Markets(http://www.researchandmarkets.com/research/a76cd4/celiac_disease_l) has announced the addition of the "Celiac Disease - Licensing Opportunities Exist in Untapped Market" report to their offering.
Low disease awareness, poor diagnosis rates, combined with a lack of pharmaceutical industry involvement, has kept celiac disease from the limelight. However, this is ...